• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 3. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694
• 4. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 5. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549

Chemical and Biological Applications of 4-Pentadecylresorcinol (CAS No. 16825-54-0)

4-Pentadecylresorcinol, with the chemical formula C??H??O? and CAS number 16825-54-0, is a unique organic compound that has garnered significant attention in the fields of chemistry and pharmaceutical research. This compound, characterized by its long alkyl chain attached to a resorcinol core, exhibits intriguing physicochemical properties that make it a promising candidate for various applications, particularly in drug development and material science. The combination of a hydrophobic alkyl group and a hydrophilic aromatic ring system imparts dual functionality, enabling interactions with both lipid and aqueous environments.

The structural motif of 4-Pentadecylresorcinol (CAS No. 16825-54-0) positions it as an excellent candidate for studying molecular recognition and self-assembly processes. Recent advancements in supramolecular chemistry have leveraged this compound to design novel nanomaterials and drug delivery systems. For instance, researchers have explored its ability to form stable micelles in aqueous solutions, which can encapsulate hydrophobic drugs and enhance their bioavailability. The long alkyl chain promotes hydrophobic interactions, while the resorcinol moiety allows for hydrogen bonding and π-π stacking interactions, facilitating the formation of organized structures.

In the realm of pharmaceutical research, 4-Pentadecylresorcinol (CAS No. 16825-54-0) has been investigated for its potential as an anti-inflammatory agent. Studies suggest that the resorcinol core can modulate inflammatory pathways by interacting with cellular receptors and enzymes. The presence of the alkyl chain further enhances its pharmacokinetic profile, allowing for targeted delivery to specific tissues. Preliminary in vitro experiments have demonstrated its ability to inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6, indicating a promising therapeutic role in chronic inflammatory diseases.

Moreover, the compound's unique structure has attracted interest in the field of cosmetics and dermatology. Its ability to penetrate the skin barrier while maintaining stability makes it an ideal candidate for formulating novel skincare products. Researchers have explored its potential as an antioxidant agent, capable of neutralizing free radicals and protecting against oxidative stress-induced skin damage. The long alkyl chain ensures adequate moisturization, while the resorcinol moiety provides additional anti-inflammatory benefits, making it a versatile ingredient in anti-aging formulations.

Recent studies have also highlighted the applications of 4-Pentadecylresorcinol (CAS No. 16825-54-0) in material science, particularly in the development of smart materials with responsive properties. The compound's ability to undergo reversible conformational changes under external stimuli has been exploited to create stimuli-responsive polymers and hydrogels. These materials have potential applications in biomedicine, such as controlled drug release systems and tissue engineering scaffolds. The long alkyl chain provides mechanical stability, while the aromatic ring system allows for functionalization with various bioactive molecules.

The synthesis of 4-Pentadecylresorcinol (CAS No. 16825-54-0) involves multi-step organic reactions, including alkylation of resorcinol followed by purification techniques such as column chromatography. Advances in synthetic methodologies have improved the yield and purity of this compound, making it more accessible for research purposes. Researchers continue to optimize synthetic routes to enhance scalability and cost-effectiveness, ensuring broader availability for industrial applications.

The biological activity of 4-Pentadecylresorcinol (CAS No. 16825-54-0) has prompted investigations into its mechanism of action at the molecular level. High-resolution structural studies using techniques such as NMR spectroscopy and X-ray crystallography have provided insights into how the compound interacts with biological targets. These studies are crucial for understanding its therapeutic potential and for designing derivatives with enhanced efficacy.

In conclusion, 4-Pentadecylresorcinol (CAS No. 16825-54-0) is a multifaceted compound with diverse applications across chemistry, pharmaceuticals, cosmetics, and material science. Its unique structure combines hydrophobicity with hydrophilicity, enabling versatile interactions with biological systems and materials. Ongoing research continues to uncover new possibilities for this compound, reinforcing its significance as a valuable chemical entity in modern science.

• 5284-29-7(2-N-Dodecylphenol)
• 18979-60-7(4-Propylbenzene-1,3-diol)
• 27193-86-8(2-Dodecylphenol)
• 1300-94-3(Amylmetacresol)
• 18979-61-8(4-Butylresorcinol)
• 136-77-6(Hexylresorcinol)
• 644-35-9(2-Propylphenol)
• 2896-60-8(4-Ethylresorcinol)
• 138-00-1(2,4-Di-tert-amyl phenol)
• 13331-19-6(2-Propylbenzene-1,3-diol)